Cargando…
Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review)
Accumulating evidence supports the notion that thyroid cancer is initiated by tumor-initiating cells (TICs) (commonly known as cancer stem cells), which are thought to play a crucial role in malignant progression, therapeutic resistance and recurrence. Thyroid TICs have been isolated and identified...
Autores principales: | GAO, YONG-JU, LI, BO, WU, XIN-YU, CUI, JING, HAN, JIAN-KUI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926673/ https://www.ncbi.nlm.nih.gov/pubmed/24424445 http://dx.doi.org/10.3892/or.2014.2978 |
Ejemplares similares
-
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
por: Prasanna, Pataje G, et al.
Publicado: (2021) -
Correction to: Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
Publicado: (2022) -
Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
por: Khandekar, Durga, et al.
Publicado: (2019) -
Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary Thyroid Carcinoma
por: Zhang, Huairong, et al.
Publicado: (2016) -
Anticancer effects of natural phytochemicals in anaplastic thyroid cancer
por: Li, Yitian, et al.
Publicado: (2022)